About: Dihomo-gamma-linolenic acid

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dihomo-gamma-linolenic acid Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/drugbank/Drug, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	http://linked.opendata.cz/ontology/drugbank/Drug
http://linked.open...gbank/description	A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5. [PubChem] (en)
http://linked.open...gy/drugbank/group	approved (en) nutraceutical (en)
http://linked.open...ugbank/indication	For nutritional supplementation, also for treating dietary shortage or imbalance (en)
sameAs	Dihomo-gamma-linolenic acid
Title	Dihomo-gamma-linolenic acid (en)
adms:identifier	http://linked.opendata.cz/resource/drugbank/drug/DB00154/identifier/chemspider/4444199 http://linked.opendata.cz/resource/drugbank/drug/DB00154/identifier/drugbank/DB00154 http://linked.opendata.cz/resource/drugbank/drug/DB00154/identifier/kegg-compound/C03242 http://linked.opendata.cz/resource/drugbank/drug/DB00154/identifier/pdb/LAX http://linked.opendata.cz/resource/drugbank/drug/DB00154/identifier/pubchem-compound/5280581 http://linked.opendata.cz/resource/drugbank/drug/DB00154/identifier/pubchem-substance/46508866 http://linked.opendata.cz/resource/drugbank/drug/DB00154/identifier/chebi/53486 http://linked.opendata.cz/resource/drugbank/drug/DB00154/identifier/pharmgkb/PA164743249
http://linked.open...mechanismOfAction	DHLA (or DGLA) is a precursor in the synthesis of prostaglandin E1 (PGE1) as well as the series-3 prostaglandins. It also serves as a precursor in the synthesis of eicosapentaenoic acid (EPA). EPA is a precursor of the series-3 prostaglandins, the series-5 leukotrienes and the series-3 thromboxanes. These eicosanoids have anti-thrombogenic, anti-inflammatory and anti-atherogenic properties. PGE1 inhibits platelet aggregation and has a vasodilation action. DHLA has also been shown to reduce the production/activity of tumor necrosis factor alpha. (en)
http://linked.open.../drugbank/synonym	gamma-Homolinolenic acid (en) (Z,Z,Z)-8,11,14-Eicosatrienoic acid (en) 8,11,14-Eicosatrienoic Acid (en) DGLA (en) Homo-gamma-linolenic acid (en) (8Z,11Z,14Z)-Icosatrienoic acid (en) (Z,Z,Z)-8,11,14-Icosatrienoate (en) (Z,Z,Z)-8,11,14-Icosatrienoic acid (en) 20:3, n-6,9,12 all-cis (en) 8c,11c,14c-Eicosatriensaeure (en) 8c,11c,14c-eicosatrienoic acid (en) C20:3, n-6,9,12 all-cis (en) Dihomo-γ-linolenic acid (en) Homo-gamma-linolensaeure (en) all-cis-8,11,14-eicosatrienoic acid (en) all-cis-8,11,14-icosatrienoic acid (en) all-cis-Eicosa-8,11,14-triensaeure (en) all-cis-eicosa-8,11,14-trienoic acid (en) all-cis-icosa-8,11,14-trienoic acid (en) cis,cis,cis-8,11,14-eicosatrienoic acid (en) eicosa-8Z,11Z,14Z-trienoic acid (en)
http://linked.open...ynthesisReference	Hiroshi Kawashima, "Process for production of dihomo-gamma-linolenic acid and lipid containing same." U.S. Patent US20010021522, issued September 13, 2001. (en)
foaf:page	http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/gam_0120.shtml
http://linked.open...ugbank/IUPAC-Name	http://linked.opendata.cz/resource/drugbank/property/271B4CE8-363D-11E5-9242-09173F13E4C5
http://linked.open...gy/drugbank/InChI	http://linked.opendata.cz/resource/drugbank/property/271B4CEE-363D-11E5-9242-09173F13E4C5
http://linked.open...Molecular-Formula	http://linked.opendata.cz/resource/drugbank/property/271B4CED-363D-11E5-9242-09173F13E4C5
http://linked.open.../Molecular-Weight	http://linked.opendata.cz/resource/drugbank/property/271B4CEA-363D-11E5-9242-09173F13E4C5
http://linked.open...noisotopic-Weight	http://linked.opendata.cz/resource/drugbank/property/271B4CEB-363D-11E5-9242-09173F13E4C5
http://linked.open...y/drugbank/SMILES	http://linked.opendata.cz/resource/drugbank/property/271B4CEC-363D-11E5-9242-09173F13E4C5
http://linked.open.../Water-Solubility	http://linked.opendata.cz/resource/drugbank/property/271B4CE6-363D-11E5-9242-09173F13E4C5
http://linked.open...ogy/drugbank/logP	http://linked.opendata.cz/resource/drugbank/property/271B4CE4-363D-11E5-9242-09173F13E4C5 http://linked.opendata.cz/resource/drugbank/property/271B4CE7-363D-11E5-9242-09173F13E4C5 http://linked.opendata.cz/resource/drugbank/property/271B4CFD-363D-11E5-9242-09173F13E4C5
http://linked.open...ogy/drugbank/logS	http://linked.opendata.cz/resource/drugbank/property/271B4CE5-363D-11E5-9242-09173F13E4C5
http://linked.open...nd-Acceptor-Count	http://linked.opendata.cz/resource/drugbank/property/271B4CF4-363D-11E5-9242-09173F13E4C5
http://linked.open...-Bond-Donor-Count	http://linked.opendata.cz/resource/drugbank/property/271B4CF5-363D-11E5-9242-09173F13E4C5
http://linked.open...drugbank/InChIKey	http://linked.opendata.cz/resource/drugbank/property/271B4CEF-363D-11E5-9242-09173F13E4C5
http://linked.open...urface-Area--PSA-	http://linked.opendata.cz/resource/drugbank/property/271B4CF0-363D-11E5-9242-09173F13E4C5
http://linked.open...nk/Polarizability	http://linked.opendata.cz/resource/drugbank/property/271B4CF2-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Refractivity	http://linked.opendata.cz/resource/drugbank/property/271B4CF1-363D-11E5-9242-09173F13E4C5
http://linked.open...atable-Bond-Count	http://linked.opendata.cz/resource/drugbank/property/271B4CF3-363D-11E5-9242-09173F13E4C5
http://linked.open.../affectedOrganism	Humans and other mammals (en)
http://linked.open...casRegistryNumber	1783-84-2 (en)
http://linked.open...drugbank/category	(en)
http://linked.open...k/Bioavailability	http://linked.opendata.cz/resource/drugbank/property/271B4CF9-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Ghose-Filter	http://linked.opendata.cz/resource/drugbank/property/271B4CFB-363D-11E5-9242-09173F13E4C5
http://linked.open...nk/MDDR-Like-Rule	http://linked.opendata.cz/resource/drugbank/property/271B4CFC-363D-11E5-9242-09173F13E4C5
http://linked.open...k/Number-of-Rings	http://linked.opendata.cz/resource/drugbank/property/271B4CF8-363D-11E5-9242-09173F13E4C5
http://linked.open...siological-Charge	http://linked.opendata.cz/resource/drugbank/property/271B4CF7-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Rule-of-Five	http://linked.opendata.cz/resource/drugbank/property/271B4CFA-363D-11E5-9242-09173F13E4C5
http://linked.open...tional-IUPAC-Name	http://linked.opendata.cz/resource/drugbank/property/271B4CE9-363D-11E5-9242-09173F13E4C5
http://linked.open...strongest-acidic-	http://linked.opendata.cz/resource/drugbank/property/271B4CF6-363D-11E5-9242-09173F13E4C5

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 39 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software